Our hosting provider is investigating network issues. We apologize for the inconvenience.

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

Gastroenterology | Apr 29, 2011

BACKGROUND & AIMS: Studies of hepatitis C virus (HCV) infection, immunopathogenesis, and resulting liver diseases have been hampered by the lack of a small animal model. We developed humanized mice with human immune system and liver tissues to improve the studies of hepatitis C virus pathogenesis and treatment. METHODS: To promote engraftment of human hepatocytes, we expressed a fusion protein of the FK506 binding protein (FKBP) and caspase 8 under control of the albumin promoter (AFC8), which induces liver cell death, in Balb/C Rag2(-/-) γC-null mice. Cotransplantation of human CD34(+) human hematopoietic stem cells (HSC) and hepatocyte progenitors into the transgenic mice led to efficient engraftment of human leukocytes and hepatocytes. We then infected these humanized mice (AFC8-hu HSC/Hep) with primary HCV isolates and studied HCV-induced immune responses and liver diseases. RESULTS: AFC8-hu HSC/Hep mice supported HCV infection in the liver and generated a human immune T-cell response against HCV. HCV infection induced liver inflammation, hepatitis, and fibrosis, which correlated with activation of stellate cells and expression of human fibrogenic genes. CONCLUSIONS: AFC8-hu HSC/Hep mice are a useful model of HCV infection, the immune response, and liver disease because they contain human immune system and liver cells. These mice become infected with HCV, generate a specific immune response against the virus, and develop liver diseases that include hepatitis and fibrosis. This model might also be used to develop therapeutics for HCV infection.

Pubmed ID: 21237170 RIS Download

Mesh terms: Animals | Caspase 8 | DNA-Binding Proteins | Disease Models, Animal | Female | Hepacivirus | Hepatitis C, Chronic | Hepatocytes | Humans | Liver Cirrhosis | Mice | Mice, Inbred BALB C | Mice, Transgenic | Stem Cells | Tacrolimus Binding Proteins | Transplantation, Heterologous

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAAA NIH HHS, Id: R21 AA018009-01
  • Agency: NIAID NIH HHS, Id: AI076142
  • Agency: NIAID NIH HHS, Id: R01 AI077454-01A2
  • Agency: NIAID NIH HHS, Id: AI077454
  • Agency: NIAID NIH HHS, Id: R21 AI076142-02
  • Agency: NIAID NIH HHS, Id: R01 AI095097
  • Agency: NIAID NIH HHS, Id: R01 AI080432-01A2
  • Agency: NIAAA NIH HHS, Id: AA018009
  • Agency: NCRR NIH HHS, Id: RR024143
  • Agency: NCRR NIH HHS, Id: UL1 RR024143
  • Agency: NIAAA NIH HHS, Id: R21 AA018009
  • Agency: NIAID NIH HHS, Id: R01 AI080432
  • Agency: NIAID NIH HHS, Id: R01 AI077454
  • Agency: NIAID NIH HHS, Id: R21 AI076142
  • Agency: NIAAA NIH HHS, Id: R21 AA018009-02
  • Agency: NIAID NIH HHS, Id: R21 AI076142-01A1
  • Agency: NIAAA NIH HHS, Id: AA018372
  • Agency: NIAID NIH HHS, Id: T32 AI007273

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.